Abigail Suzanne Caudle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Abigail Suzanne Caudle has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Henry M. Kuerer
Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
8 shared publicationsKelly K. Hunt
Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
8 shared publicationsElizabeth A. Mittendorf
Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
7 shared publicationsIsabelle Bedrosian
Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
4 shared publicationsSavitri Krishnamurthy
Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
4 shared publicationsAysegul A. Sahin
Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
3 shared publications
Latest Publications
- Open Access
Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer
(1) Background: The relatively high rate of contralateral prophylactic mastectomy (CPM) among women with early stage unilateral breast cancer (BC) has raised concerns. We sought to assess the influence of partners, physicians, and the media on the decision of women with unilateral BC to undergo CPM and identify clinicopathological variables associated with the decision to undergo CPM. (2) Patients and Methods: Women with stage 0 to III unilateral BC who underwent CPM between January 2010 and December 2017. Patients were surveyed regarding factors influencing their self-determined decision to undergo CPM. Partner, physician, and media influence factors were modeled by logistic regressions with adjustments for a family history of breast cancer and pathological stage. (3) Results: 397 (29.6%) patients completed the survey and were included in the study. Partners, physicians, and the media significantly influenced patients’ decision to undergo CPM. The logistic regression models showed that, compared to self-determination alone, overall influence on the CPM decision was significantly higher for physicians (p = 0.0006) and significantly lower for partners and the media (p < 0.0001 for both). Fifty-nine percent of patients’ decisions were influenced by physicians, 28% were influenced by partners, and only 17% were influenced by the media. The model also showed that patients with a family history of BC had significantly higher odds of being influenced by a partner than did those without a family history of BC (p = 0.015). (4) Conclusions: Compared to self-determination, physicians had a greater influence and partners and the media had a lower influence on the decision of women with unilateral BC to undergo CPM. Strong family history was significantly associated with a patient’s decision to undergo CPM.
Open AccessInfluencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer
(1) Background: The relatively high rate of contralateral prophylactic mastectomy (CPM) among women with early stage unilateral breast cancer (BC) has raised concerns. We sought to assess the influence of partners, physicians, and the media on the decision of women with unilateral BC to undergo CPM and identify clinicopathological variables associated with the decision to undergo CPM. (2) Patients and Methods: Women with stage 0 to III unilateral BC who underwent CPM between January 2010 and December 2017. Patients were surveyed regarding factors influencing their self-determined decision to undergo CPM. Partner, physician, and media influence factors were modeled by logistic regressions with adjustments for a family history of breast cancer and pathological stage. (3) Results: 397 (29.6%) patients completed the survey and were included in the study. Partners, physicians, and the media significantly influenced patients’ decision to undergo CPM. The logistic regression models showed that, compared to self-determination alone, overall influence on the CPM decision was significantly higher for physicians (p = 0.0006) and significantly lower for partners and the media (p < 0.0001 for both). Fifty-nine percent of patients’ decisions were influenced by physicians, 28% were influenced by partners, and only 17% were influenced by the media. The model also showed that patients with a family history of BC had significantly higher odds of being influenced by a partner than did those without a family history of BC (p = 0.015). (4) Conclusions: Compared to self-determination, physicians had a greater influence and partners and the media had a lower influence on the decision of women with unilateral BC to undergo CPM. Strong family history was significantly associated with a patient’s decision to undergo CPM.
- 8 January 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (8) , 4277-4283
Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients
Targeted axillary dissection (TAD) involves locating and removing both clipped nodes and sentinel nodes for assessment of the axillary response to neoadjuv
- 8 January 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (8) , 4277-4283
Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients
Targeted axillary dissection (TAD) involves locating and removing both clipped nodes and sentinel nodes for assessment of the axillary response to neoadjuv
- 24 July 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 26 (10) , 3040-3045
Sentinel Node Lymph Node Surgery After Neoadjuvant Therapy: Principles and Techniques
Surgical management of the axilla in breast cancer has been a topic of great interest. While sentinel lymph node biopsy (SLNB) is an established approach for patients undergoing surgical treatment as the first element of their care, there is continued debate regarding surgical management of the axilla in patients receiving neoadjuvant chemotherapy (NAC). In clinically node-negative patients, it has been debated whether or not SLNB should be performed before chemotherapy to accurately determine the clinical stage, or after chemotherapy, thus prioritizing the response to therapy and potentially minimizing axillary surgery. Node-positive patients have undergone axillary lymph node dissection in the past, however this paradigm has been challenged in recent years. Thus, surgeons must understand the importance of accurate axillary information both before and after NAC, and its role in multidisciplinary planning. We present a summary of the data surrounding axillary management in patients receiving NAC, and recommendations for surgical technique.
- 24 July 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 26 (10) , 3040-3045
Sentinel Node Lymph Node Surgery After Neoadjuvant Therapy: Principles and Techniques
Surgical management of the axilla in breast cancer has been a topic of great interest. While sentinel lymph node biopsy (SLNB) is an established approach for patients undergoing surgical treatment as the first element of their care, there is continued debate regarding surgical management of the axilla in patients receiving neoadjuvant chemotherapy (NAC). In clinically node-negative patients, it has been debated whether or not SLNB should be performed before chemotherapy to accurately determine the clinical stage, or after chemotherapy, thus prioritizing the response to therapy and potentially minimizing axillary surgery. Node-positive patients have undergone axillary lymph node dissection in the past, however this paradigm has been challenged in recent years. Thus, surgeons must understand the importance of accurate axillary information both before and after NAC, and its role in multidisciplinary planning. We present a summary of the data surrounding axillary management in patients receiving NAC, and recommendations for surgical technique.
- Open Access
- 7 January 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 26 (4) , 930-932
Do Internal Mammary Nodes Matter?
- 7 January 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 26 (4) , 930-932
Open AccessDo Internal Mammary Nodes Matter?
Feasibility of fine‐needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study
Background: Clips are often placed to mark axillary nodes with biopsy‐confirmed metastases in patients with breast cancer. The evaluation of clipped nodes after chemotherapy can identify patients who have eradication of nodal disease. The goal of this study was to determine whether preoperative fine‐needle aspiration (FNA) of clipped nodes after neoadjuvant chemotherapy (NAC) could predict the presence of residual disease. Methods: This prospective registry study enrolled 50 patients with a clip placed to mark nodes with biopsy‐confirmed metastases who had completed NAC. Participants underwent FNA of the clipped node before seed‐localized lymph node excision. FNA pathology was compared with surgical pathology. Results: There were 36 patients (72%) with residual disease on surgical pathology: 3 (8%) had a nondiagnostic aspirate, carcinoma was seen in 14 (39%), and 19 (53%) had a false‐negative result. The sensitivity of FNA was 42.4%, its specificity was 100%, and its negative predictive value was 40.6%. In a univariate analysis, the odds of a true‐positive result increased significantly with the mean initial size of the clipped node (odds ratio [OR], 4.3; P = .004) and the size of the metastatic focus after NAC (OR, 1.3; P = 0.003), whereas normalization of nodes after chemotherapy (OR, 0.1) and a lack of response on ultrasound (OR, 0.11) were associated with a false‐negative result ( P = .01). Conclusions: FNA of marked nodes after chemotherapy has a high false‐negative rate. This highlights the need for surgical staging of the axilla after NAC to assess the response.
Feasibility of fine‐needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study
Background: Clips are often placed to mark axillary nodes with biopsy‐confirmed metastases in patients with breast cancer. The evaluation of clipped nodes after chemotherapy can identify patients who have eradication of nodal disease. The goal of this study was to determine whether preoperative fine‐needle aspiration (FNA) of clipped nodes after neoadjuvant chemotherapy (NAC) could predict the presence of residual disease. Methods: This prospective registry study enrolled 50 patients with a clip placed to mark nodes with biopsy‐confirmed metastases who had completed NAC. Participants underwent FNA of the clipped node before seed‐localized lymph node excision. FNA pathology was compared with surgical pathology. Results: There were 36 patients (72%) with residual disease on surgical pathology: 3 (8%) had a nondiagnostic aspirate, carcinoma was seen in 14 (39%), and 19 (53%) had a false‐negative result. The sensitivity of FNA was 42.4%, its specificity was 100%, and its negative predictive value was 40.6%. In a univariate analysis, the odds of a true‐positive result increased significantly with the mean initial size of the clipped node (odds ratio [OR], 4.3; P = .004) and the size of the metastatic focus after NAC (OR, 1.3; P = 0.003), whereas normalization of nodes after chemotherapy (OR, 0.1) and a lack of response on ultrasound (OR, 0.11) were associated with a false‐negative result ( P = .01). Conclusions: FNA of marked nodes after chemotherapy has a high false‐negative rate. This highlights the need for surgical staging of the axilla after NAC to assess the response.
- 1 October 2018
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 25 (11) , 3112-3114
Intraoperative Pathologic Evaluation with Targeted Axillary Dissection
- 1 October 2018
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 25 (11) , 3112-3114
Intraoperative Pathologic Evaluation with Targeted Axillary Dissection
- 1 August 2018
- Published by Elsevier in Surgical Clinics of North America
- Vol. 98 (4) , 747-760
Management of the Axilla in the Patient with Breast Cancer
- 1 August 2018
- Published by Elsevier in Surgical Clinics of North America
- Vol. 98 (4) , 747-760
Management of the Axilla in the Patient with Breast Cancer
- 1 August 2018
- Published by Elsevier in Clinical Breast Cancer
- Vol. 18 (4) , 276-281
Expanding Implementation of ACOSOG Z0011 in Surgeon Practice
- 1 August 2018
- Published by Elsevier in Clinical Breast Cancer
- Vol. 18 (4) , 276-281
Expanding Implementation of ACOSOG Z0011 in Surgeon Practice